Ultragenyx Pharmaceutical | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Agios Pharmaceuticals USD 45.87M 4.34M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Insmed USD 76.44M 71.11M 2025-06
Ionis Pharmaceuticals USD 90.6M 14.6M 2025-06
Kyowa Hakko Kirin JPY 40.78B 1.26B 2025-06
MacroGenics USD 27.81M 13.71M 2024-12
Moderna USD 230M 18M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
PTC Therapeutics USD 85.26M 76.66M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Sarepta Therapeutics USD 69.89M 63.74M 2025-06
Ultragenyx Pharmaceutical USD 86.65M 1.15M 2025-06
Vertex Pharmaceuticals USD 424.6M 28.2M 2025-06


Ultragenyx Pharmaceutical Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.